National Asset Management, Inc. Vivos Therapeutics, Inc. Transaction History

National Asset Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$1.12 - $2.18 $2,494 - $4,854	2,227 Added 2.26%	100,801 $131,000
Q1 2022 May 02, 2022	BUY	$1.63 - $3.63 $31,465 - $70,073	19,304 Added 24.35%	98,574 $265,000
Q4 2021 Jan 28, 2022	BUY	$2.25 - $4.11 $63,636 - $116,243	28,283 Added 55.47%	79,270 $179,000
Q3 2021 Nov 16, 2021	BUY	$2.71 - $5.9 $44,088 - $95,987	16,269 Added 46.86%	50,987 $206,000
Q2 2021 Aug 10, 2021	BUY	$4.83 - $9.67 $30,144 - $60,350	6,241 Added 21.92%	34,718 $172,000
Q1 2021 May 13, 2021	BUY	$6.01 - $8.9 $171,146 - $253,445	28,477 New	28,477 $190,000

Ticker VVOS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 23,012,100
Market Cap $60.3M
Description
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on National Asset Management, Inc. with notifications on news.